The Multibillion-Dollar Opioid Crisis Has a Plant Medicine Solution

In “The Multibillion-Dollar Opioid Crisis Has a Plant Medicine Solution,” it’s easy to forget that author Omri Wallach isn’t referring to the US, and it’s raging opioid crisis. Rather, Wallach is commenting on Canada, a country that for most around the world has a reputation for stability and order. But that Canadian calmness is no match for opioid addiction, which has positioned alternative drug rehabilitation front and center in this northern country. 

Taking a chapter out of ibogaine treatment in Mexico and the great strides this psychedelic substance has made with opioid, methamphetamine, cocaine and heroin rehabilitation, Wallach details some novel moves the Canadian private sector is taking to be an eventual global example of the application of ibogaine as a verifiable treatment. The most promising news, however, is not that ibogaine is finally being considered as one of the premier alternative drug rehabilitation psychedelics. Rather, the Canadian government is also coming along to the idea that making a dent in curbing a death toll that took 4,460 Canadian lives in 2018 can be achieved with alternatives to the norm. 

Read the full article here:

Could ibogaine offer a revolutionary long-term solution to addiction?

The United States and many other countries worldwide have been completely ravaged by the opioid crisis. While the World Health Organization reports that roughly 3.3 million people die yearly from alcohol addiction, a staggering 31 million people suffer from substance use disorders. And the root cause of these disorders are psychological and emotional in nature. Deep-seated traumas are common with not only opioid addiction, but heroin addiction, methamphetamine, and cocaine, among others. Fentanyl is a powerful, synthetic opioid and hundreds of millions are spent each year in costly fentanyl detox. 

As this informative article, “Could ibogaine offer a revolutionary long-term solution to addiction?” from HealthEuropa, details, researchers are beginning to understand better how alternative drug rehabilitation, especially with ibogaine is different, and in many cases superior to what many have been engaged in up to now. Ibogaine was (and still is) used in religious Bwiti ceremonies by the Punu and Mitsogo people in Gabon and Cameroon. It takes the user on a journey, confronting some of their most painful and regrettable decisions, and pinpoints the root causes of said decisions. The journey is far from enjoyable, but valuable and leaving the user in many cases not seeking to self-medicate afterward.  

Read the full article here:

Iboga in 2020: Why Now Is The Time To Embrace Oneirogenics

Heroin rehabilitation, weening yourself off cocaine, opioid addiction, these are heavy issues that most societies have had a lot of experience with. The problem – said experience has not resulted in great treatment. For numerous reasons, most treatment for drug addiction rests on the use of pharmeceutical drugs and treating patients in a very hierarchical fashion. Levels of addiction are defined, and the correspinding cocktail of drugs is subsequently assigned. 

The results have not been great, and as “Iboga in 2020: Why Now Is The Time To Embrace Oneirogenics” rightly points out – oneirogenics is poised for a big breakthrough moving forward. An oneirogneic state is achieved via high-doses of psychedelic substances such as ibogaine. Ibogaine treatment in Mexico for folks with a range of additions has been lauded as a revolutionary step forward, and ibogaine has proved successful in taking patients back through their formative years and painful moments that have resulted in a current addiction. By confronting the difficult, ibogaine hits at the root of the addiction or psychiatric state, thus giving treatment practitioners much more to work with than simply states of mind with little context. 

Read the full article here:

How Ibogaine Can Help with the Opioid Crisis

Juliana was like many other addicts. Heroin rehabilitation was part of a never-ending cycle of breaking her addiction, only to see it return weeks or months later. She had heard of ibogaine treatment in Mexico and throughout Latin America and Europe but naturally had her doubts. It wasn’t until her mother and a close friend’s support led her to a clinic where she received ibogaine treatment for the first time. 

Adaam James Levin-Areddy takes us through Juliana’s journey in “How Ibogaine Can Help with the Opioid Crisis,” eventually leading us to the future of ibogaine treatment strategies for everything from heroin to fentanyl detox. While there have not been any double-blind, randomized clinical trials with ibogaine yet, a vast majority of those that have been surveyed, post-treatment, have experienced relapses at a lower frequency. However, convincing pharmaceutical companies to jump on board without a clinical trial will certainly be a challenge. But if Juliana’s story is any indication of the efficacy of this naturally occurring substance, people should and will continue to pay attention.

Read the full article here: